NAVLIN Price & Access Data
NAVLIN Price & Access Data is a powerful competitor intelligence tool that provides near real-time updates to drug price (list / net), reimbursement, tender and cost of treatment information at the indication level.
Our team of experts track real time pricing changes across 87+ markets and 200+ therapeutic areas and develop county profiles to inform global pricing and market access strategies for our pharma clients.
Articles by NAVLIN Price & Access Data
Strategic PICO Planning: Navigating Oncology Markets with NAVLIN by EVERSANA
Strategic PICO Planning in Oncology Markets In today’s dynamic healthcare environment, early and strategic PICO (Population, Intervention, Comparator, Outcome) planning is critical to successful evidence generation. With evolving regulatory frameworks—like the European Joint Clinical Assessment (JCA)—now leveraging PICOs to guide therapy evaluations, NAVLIN by EVERSANA® enables clients to anticipate HTA requirements, align internal stakeholders, and […]
Strategic PICO Planning: Enhancing Early-Phase Development for Market Access
Future-Proofing Early Development with Strategic PICO Planning A global pharmaceutical company with a diverse pipeline needed to align early clinical planning with future market access requirements—before Phase II. With Target Product Profiles (TPPs) still in development, the team turned to NAVLIN by EVERSANA® to anticipate EU Joint Clinical Assessment (JCA) expectations and build a strategic […]
Unlocking the Power of Tender Data to Drive Post-LOE Pricing Strategy
In the world of pharmaceuticals, pricing strategy becomes especially critical after the loss of exclusivity (LOE) for blockbuster drugs. Once patent protection ends, competition from generics or biosimilars floods the market, leading to significant price erosion. However, there’s an opportunity that many companies overlook: leveraging tender data to maintain a competitive edge and optimize pricing […]